Pharmacy Owners Say They Are Unable to Participate in MDPNP

Nearly 1 in 5 pharmacy owners have expressed that they will not be participating in the Medicare Drug Price Negotiation Program (MDPNP) because of its potential to increase cashflow issues and decrease revenue. Up to 67% of owners are considering not stocking the drugs included under the negotiations, according to a National Community Pharmacists Association (NCPA) news release.¹

“Independent pharmacists want this program to work, and they want to participate,” said NCPA CEO Douglas Hoey, RPh, MBA, according to the release. “But the program must be implemented in a way that makes business sense or independent pharmacies won’t be able to…